Logo

Colon cancer DNA may guide tailored post-surgery care

Colon cancer DNA may guide tailored post-surgery care

Circulating tumor DNA (ctDNA)—genetic material shed from tumors into the bloodstream—may help risk-stratify patients with Stage 3 colon cancer by tailoring chemotherapy options after surgery based on risk of cancer recurrence, according to new research co-led by investigators at the Johns Hopkins Kimmel Cancer Center.

👉 Full Story